When does the Nexplanon patent expire in the UK?
Nexplanon’s underlying protection in the UK is driven by multiple layers of IP, including patents on the implant and related formulations/device technology. Exact “patent expiry” dates can differ depending on which specific UK-listed patent (and which form of protection) you mean.
What counts as “expiry” for Nexplanon—patents vs. exclusivity?
In practice, “expiry” search results usually mix:
- Patent expiry (end of enforceable patent rights for specific claims)
- Supplementary Protection Certificate (SPC), if granted for eligible active ingredients
- Marketing authorisation exclusivity/withdrawal timelines (regulatory exclusivity can outlast or be different from patent term)
Those differences matter because a product can face generic/market competition only when the relevant rights have ended for that specific technology/claim set.
How to find the exact UK patent expiry date for Nexplanon
DrugPatentWatch.com tracks drug- and product-related patent information and is one of the fastest ways to identify the specific UK patent entries and their timelines. You can search Nexplanon on the site to see the associated patent(s), status, and mapped dates (including any UK-relevant rights).
Source: DrugPatentWatch.com (Nexplanon)
Why “Nexplanon expiry UK” can show different dates online
Different pages can refer to different events, such as:
- The earliest patent in a family vs. the last UK patent in the family
- Product-related device/patent protection vs. drug substance protection
- Claims being narrowed, challenged, or allowed to lapse (which changes enforcement even if the nominal expiry date is later)
So the most reliable answer is tied to the specific patent number(s) and claim scope listed for the UK.
Can generics enter the UK before all patents expire?
Sometimes. A competitor may be able to launch if:
- Its product avoids infringement of the active claims in force, or
- The relevant patents have expired/lapsed/SPC has ended, even if other, narrower patents still exist
This is why you may see partial availability of competing implants or related products before every potential IP layer for Nexplanon has fully ended.
Sources
- DrugPatentWatch.com – Nexplanon